Sell RIM!: Against ...
Health Care: Drugs
Catalyst Pharmaceutical Partners Inc. (CPRX: NASDAQ)
$0.57 0.00 | 0.04%
06/04/12 - 03:54 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| CPRX | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -49.33 | -51.71 | -37.51 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -100.00 | 0.00 | 0.00 |
| Net Income | -0.40 | 0.00 | |
| EPS | -0.64 | 0.00 |
Earnings for CPRX:
| EBITDA | -6.00 |
| REVENUE | 0.00 |
Average Earnings Estimates
| Qtr (06/12) | Qtr (09/12) | FY (12/12) | FY (12/13) | |
|---|---|---|---|---|
| Average Estimate | $-0.06 | $-0.06 | $-0.23 | $-0.28 |
| Number of Analysts | 1 | 1 | 2 | 2 |
| High Estimate | $-0.06 | $-0.06 | $-0.20 | $-0.23 |
| Low Estimate | $-0.06 | $-0.06 | $-0.25 | $-0.33 |
| Prior Year | $-0.06 | $-0.05 | $-0.28 | $-0.23 |
| Growth Rate (Year over Year) | 0.00% | -20.00% | 19.64% | -24.44% |
Portfolios with CPRX
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE EX-1006090013 DE...
- Userzhuangsn
- UserBRR Portfolio 1
- Userjaxplace Portfolio 1
- Usersovnek Portfolio 1
- UserDj Paul
- Userlouiis Portfolio 1
- Usercjthurman Portfolio 1
- Userajsny Portfolio 1
Latest CPRX Headlines from TheStreet
- 5 Stocks Setting Up to Break Out 12.20.11 | 01:12 pm
- Catalyst Announces Commencement Of CPP-109 Investigator-Sponsored Study In Cocaine And Alcohol Co-Dependent Patients 03.29.11 | 08:03 am
- Catalyst Pharmaceutical Partners To Present At The ROTH 23rd Annual OC Growth Stock Conference 03.09.11 | 11:03 am
- Catalyst Pharmaceutical Partners, Inc. Announces Public Offering Of Common Shares 03.08.11 | 09:03 am
- Catalyst Pharmaceutical Partners Promotes Steven R. Miller, Ph.D. To Chief Operating Officer 01.25.11 | 08:01 am
- Catalyst Pharmaceutical Partners To Present At The Biotech Showcase(TM) 2011 Conference 01.04.11 | 08:01 am
- Canadian Intellectual Property Office Grants Broad Patent For The Use Of Vigabatrin/CPP-109 For The Prevention Of Addiction In Pain Management 12.09.10 | 08:12 am
- Catalyst Pharmaceutical Partners Initiates A Registration-Directed U.S. Phase II(b) Clinical Trial In Collaboration With The National Institute On Drug Abuse And Veteran's Administration Cooperative Studies Program 11.18.10 | 08:11 am
- Catalyst Pharmaceutical Partners Announces Third Quarter 2010 Financial And Operational Results 11.16.10 | 08:11 am
- Dr. Richard B. Silverman Joins Catalyst Pharmaceutical Partners' Scientific Advisory Board 11.15.10 | 08:11 am
Press Releases for CPRX
- Vigabatrin/CPP-109 Data To Be Presented At College On Problems Of Drug Dependence Annual Meeting - PR Newswire 06.09.10 | 08:06 am
- Catalyst Pharmaceutical Partners To Present At The MoneyShow Conference - PR Newswire 05.07.10 | 08:05 am
- Catalyst Pharmaceutical Partners Regains Compliance With NASDAQ Minimum Bid Price Rule - PR Newswire 04.26.10 | 11:04 am
- Catalyst Pharmaceutical Partners Signs Definitive Agreement With The National Institute On Drug Abuse To Conduct U.S. Phase II(B) Clinical Trial For Cocaine Addiction - PR Newswire 04.13.10 | 10:04 am
- CPP-109 Clinical Trial Data To Be Presented At The American Society Of Addiction Medicine Annual Medical-Scientific Conference - PR Newswire 04.09.10 | 08:04 am
- Catalyst Pharmaceutical Partners Reports Fourth Quarter And Year-End 2009 Financial Results - PR Newswire 04.01.10 | 08:04 am
- Catalyst Pharmaceutical Partners To Present At The BioNetwork East 2010 Conference - PR Newswire 03.10.10 | 08:03 am
- Catalyst Pharmaceutical Partners To Present Today At 2010 Epilepsy Pipeline Update Conference - PR Newswire 02.25.10 | 08:02 am
- Catalyst Pharmaceutical Partners And The National Institute On Drug Abuse Plan To Initiate U.S. Phase II(b) Clinical Trial For Cocaine Addiction - PR Newswire 02.23.10 | 08:02 am
- Catalyst Pharmaceutical Partners Selected To Present At Epilepsy Conference Highlighting New And Promising Therapies - PR Newswire 02.17.10 | 08:02 am
Partner Headlines for CPRX
- Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN - GuruFocus 06.04.12 | 01:06 pm
- 7 Stocks Under $6 Poised To Double In 2012 - Seeking Alpha 11.24.11 | 06:11 am
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 10.14.11 | 09:10 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 10.10.11 | 09:10 am
- Morning Market Losers - Benzinga 06.06.11 | 09:06 am
- 7 Big Movers That Investors Must Watch This Week - Seeking Alpha 06.06.11 | 08:06 am
- 7 Dirt-Cheap Takeover Targets in Biotech - Seeking Alpha 06.03.11 | 09:06 am
- Orphan Status for Catalyst Drug - Analyst Blog - Zacks 09.22.10 | 06:09 pm
- Biotech's Slow Week Gets Stirred by a Few Smaller Deals - Seeking Alpha 08.15.10 | 04:08 am
